NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States Remove constraint Subjects: United States Genre Technical Report Remove constraint Genre: Technical Report Copyright Copyright may apply Remove constraint Copyright: Copyright may apply Recently Added Within 6 Months Remove constraint Recently Added: Within 6 Months

Search Results

2. Training the primary care workforce to deliver team based care in underserved areas: the teaching health center program

5. Catalyzing Medicaid policy research with T-MSIS Analytic Files (TAF): learnings from year 1 of the Medicaid Data Learning Network (MDLN)

6. Medicaid in midlife: a profile of enrollees ages 50 to 64

10. It leaves me feeling defeated: searching for in-network mental health care with marketplace insurance

11. Belimumab and voclosporin for lupus nephritis: effectiveness and value : final report

12. Treatments for anemia in chronic kidney disease: effectiveness and value : final evidence report

13. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: Effectiveness and value : final report

19. Consolidated Appropriations Act, 2023: Medicaid and CHIP provisions explained

20. Mixed results: state employee health plans face challenges, find opportunities to contain cost growth

25. Unwinding the Medicaid continuous coverage protection at the end of the COVID public health emergency: tips and best practices

26. State fiscal incentives for Medicaid expansion continue after the end of public health emergency

29. Evidence on the effectiveness of programs, models, and strategies to support employment outcomes of young adults on the autism spectrum: a review of the literature

30. How did the COVID-19 pandemic affect the education and employment of young people with disabilities?: findings from the Promoting Readiness of Minors in Supplemental Security Income (PROMISE) evaluation

32. Promoting readiness of minors in Supplemental Security Income (PROMISE). Youth and family outcomes five years after enrollment

36. Data brief: sexual and reproductive health services among people with employer sponsored insurance

37. Gene therapies for sickle cell disease: final evidence report

38. Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH): final evidence report

39. Lecanemab for early Alzheimer’s disease: final evidence report

40. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value : final evidence report

41. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value : final evidence report

42. Tezepelumab for severe asthma: final report

43. Fezolinetant for moderate to severe vasomotor symptoms associated with menopause: effectiveness and value : final evidence report

44. Gene therapy for hemophilia B and an update on gene therapy for hemophilia A: effectiveness and value : final evidence report

45. Special assessment of outpatient treatments for COVID-19: nirmatrelvir/ritonavir (Paxlovid) health-benefit price benchmark update

46. Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pre-treated relapsed and refractory multiple myeloma: final report

47. Health care affordability improved between 2019 and 2022 under pandemic health coverage policies: findings from the Well-Being and Basic Needs Survey